CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $22,000 | -72.5% | 4,500 | -62.0% | 0.01% | -82.1% |
Q2 2020 | $80,000 | +515.4% | 11,850 | +492.5% | 0.03% | +300.0% |
Q1 2020 | $13,000 | -27.8% | 2,000 | +14.3% | 0.01% | -22.2% |
Q4 2019 | $18,000 | -60.9% | 1,750 | -85.2% | 0.01% | -64.0% |
Q3 2019 | $46,000 | -75.3% | 11,800 | -5.6% | 0.02% | -76.9% |
Q2 2019 | $186,000 | -17.0% | 12,500 | +0.4% | 0.11% | -26.5% |
Q4 2018 | $224,000 | -46.2% | 12,450 | -12.0% | 0.15% | -31.6% |
Q3 2018 | $416,000 | -31.5% | 14,150 | +6.0% | 0.22% | -34.0% |
Q2 2018 | $607,000 | -13.9% | 13,350 | 0.0% | 0.33% | -15.3% |
Q1 2018 | $705,000 | +6.3% | 13,350 | +36.9% | 0.38% | +6.4% |
Q4 2017 | $663,000 | -23.9% | 9,750 | -7.8% | 0.36% | -29.4% |
Q3 2017 | $871,000 | +3.7% | 10,575 | +17.8% | 0.51% | -2.5% |
Q2 2017 | $840,000 | +210.0% | 8,975 | +111.2% | 0.53% | +211.2% |
Q1 2017 | $271,000 | +16.3% | 4,250 | -19.0% | 0.17% | +15.8% |
Q4 2016 | $233,000 | -56.4% | 5,250 | -64.6% | 0.15% | -57.4% |
Q3 2016 | $535,000 | +181.6% | 14,850 | +7.2% | 0.34% | +178.9% |
Q2 2016 | $190,000 | -59.6% | 13,850 | -43.5% | 0.12% | -60.8% |
Q1 2016 | $470,000 | -26.0% | 24,500 | +35.0% | 0.31% | -22.9% |
Q4 2015 | $635,000 | +129.2% | 18,150 | +476.2% | 0.41% | +142.3% |
Q2 2015 | $277,000 | +18.4% | 3,150 | 0.0% | 0.17% | +17.5% |
Q1 2015 | $234,000 | -81.6% | 3,150 | -86.2% | 0.14% | -81.6% |
Q4 2014 | $1,274,000 | -11.0% | 22,750 | -27.9% | 0.78% | -6.8% |
Q3 2014 | $1,431,000 | +72.0% | 31,550 | +57.0% | 0.83% | +84.1% |
Q2 2014 | $832,000 | +84.1% | 20,100 | +168.0% | 0.45% | +55.7% |
Q4 2013 | $452,000 | – | 7,500 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |